←
Johnson Thomas, MD, FACE5,275 posts
Johnson Thomas, MD, FACE avatar

Johnson Thomas, MD, FACE

@JohnsonThomasMD

Endocrinologist. Editor in Chief - Endocrine AI. Section chair. Passionate about thyroid nodules, cancer & AI. Creator of Endo Tools iphone app, AIBx.

◷ Joined April 2012▧ 580 Photos and videos
Johnson Thomas, MD, FACE avatar
Johnson Thomas, MD, FACE@JohnsonThomasMD·Oct 10

Free, open source #thyroid risk stratification model for research. Anyone can create similar models without coding. Read our paper @EndoSocJournals link in comments @croendoyoung @Thyroid_ITS @TheEndoSociety @EndocrineToday @TIRO_expert @ETA_Thyroid @thyroid thyronaut.com/

Johnson Thomas, MD, FACE avatar
Johnson Thomas, MD, FACE@JohnsonThomasMD·Nov 14

Why it matters: ✅ Fully transparent — every weight is tied to a measurement a radiologist can check ✅ Tiny — ~300 lines of code + a few KB of numbers, vs. ~11 million parameters in a small CNN ✅ Adaptable — a new question means writing a new measurement, not retraining a network ✅ Private — small enough to run entirely in the browser, so the image never leaves your computer ✅ Guarded against self-grading — fixed scorers, a rule-checking auditor, and hidden test sets the agent never sees

Johnson Thomas, MD, FACE avatar
Johnson Thomas, MD, FACE@JohnsonThomasMD·Nov 14

We applied that idea to ACR TI-RADS: 🔹 Step 1 – Outlining the nodule: an AI agent writes classical image-processing code (no CNN, no U-Net) and is scored against open source nodule masks. 🔹 Step 2 – Describing the nodule: the agent writes named measurements that mirror the TI-RADS lexicon — "solid-part brightness ÷ surrounding thyroid" for echogenicity, height ÷ width for shape, boundary roughness for margins, bright-spot detection for echogenic foci. 🔹 Step 3 – Scoring: a tiny logistic model per descriptor, then the standard ACR point system gives the TR level.

Johnson Thomas, MD, FACE avatar
Johnson Thomas, MD, FACE@JohnsonThomasMD·Nov 14

Can you build a thyroid ultrasound AI with no neural network at all — and still read every step of it? That's what we're testing with iWSP TI-RADS. The inspiration: a paper posted this week from @MSFTResearch @JohnsHopkins @NYUDataScience and @Columbia - "Interpretable Weight-Space Programming Builds Transparent Transformers and Brain Encoding Models" (@y_mehtu et al.). Instead of training a model with backpropagation, an AI agent writes the model directly as readable code, tests it, and revises it over many rounds.

4:20
Endocrine Today avatar
⟳ Johnson Thomas, MD, FACE retweeted
Endocrine Today@EndocrineToday·Nov 13

💡 Levothyroxine alone provided better quality of life than combination levothyroxine/liothyronine in several domains, including: 📌 tiredness 📌 cognition 📌 anxiety 📌 depression #ATA2026 @AmThyroidAssn @EndocrinologyM vist.ly/5sqsp

Johnson Thomas, MD, FACE avatar
Johnson Thomas, MD, FACE@JohnsonThomasMD·Nov 12

Stopping a GLP-1 after starting it was linked to about twice the rate of heart attack, stroke, or death in type 2 diabetes: 3.94 vs 1.96 per 100 person-years. All-cause death was 2.23 vs 0.48. Observational, so not proven cause, and reasons for stopping were unknown. Still, a reminder to plan the stop, not just stop. doi.org/10.1016/j.lanepe.202…

AACE avatar
⟳ Johnson Thomas, MD, FACE retweeted
AACE@TheAACE·Nov 11

Early-career endocrinologists: Here's your opportunity to grow as a leader and help shape the future of our specialty! The new Daniel L. Hurley, MD, MACE AACE Emerging Leaders Initiative Award offers mentorship, leadership development, and opportunities to become more engaged in the future of endocrinology. Be the inaugural recipient of this exciting new award and submit your self-nomination by the December 11, 2026. Learn more about the requirements here pro.aace.com/about/aace-awar… Don't miss the chance to invest in your leadership development and professional growth!

Post attachment
Johnson Thomas, MD, FACE avatar
Johnson Thomas, MD, FACE@JohnsonThomasMD·Nov 11

ATTAIN-OSA in JAMA: oral orforglipron (Foundayo) cut AHI by 12-13 events/h more than placebo at 52 weeks in adults with obesity and moderate to severe OSA, on or off PAP. Weight down ~10%. GI side effects were common. Not yet approved for OSA. jamanetwork.com/journals/jam…

Milos Vukadinovic avatar
⟳ Johnson Thomas, MD, FACE retweeted
Milos Vukadinovic@milos_ai·Nov 9

AI-Generated Echo Reports Pass a Clinical Turing Test We tested AI-generated echo reports in a blinded, randomized clinical trial. Clinicians could not reliably tell which reports were written by AI and which by a cardiologist.

1/n Excited to share AI ECHO INSIGHT, the first blinded, randomized trial of AI for the full echo report, presented today by Keane Lee at #ScientificSessions26 Late-Breaking Science. EchoPrime and EchoNet-Measurements drafted the interpretations and measurements for cardiologist review. #echofirst

0:29